Received Sep 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z008866 | OT |
a dose of PROQUAD was administered to a patient after it was not stored immediately and sat in the sealed shipping container; No adverse effects were noted.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Z008866, expiration date reported as 10-Nov-2026) 0.5 mL (route of administration and anatomical location of vaccine were not reported), the vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (lot #, expiration date and dose were not reported) administered for prophylaxis. This dose of was administered to the patient after it was not stored immediately and sat in the sealed shipping container (Product storage error). The nurse used the room temperature as the maximum temperature for a worst case scenario temperature excursion evaluation; the registered temperature was 75 Fahrenheit for 6 hours. No adverse effects were noted. No additional information was provided to further clarify the details. Follow-up information was received from the nurse on 03-Sep-2025. This report referred to a 4-year-old male patient.
DILUENT MRK